A Study of LY2835219 in Healthy Participants

NCT02327143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY2835219
DRUG: ¹³C₈-LY2835219

Sponsor

Eli Lilly and Company